Node IGTT
Speaker: Gerd Heilemann, Ivo Florian Rausch
What is IGTT?
At the IGTT node, we develop and clinically explore advanced imaging-based therapeutic concepts to improve both the effectiveness and the minimal invasiveness of treatments. Our work spans image-guided radiotherapy, interventional oncology, vascular therapies, and radionuclide theranostics—combining diagnostic imaging and targeted therapy for personalized patient care.
Our Vision
See Better. Understand Better. Treat Best.
Our philosophy highlights the important relationship between diagnostic imaging and accurate treatment delivery. By leveraging a broad range of imaging modalities—from CT and MRI to PET and SPECT, hybrid imaging units, and beyond—we aim to refine how physicians diagnose, plan, guide, and monitor therapies in real time. This approach ensures treatments are not only more accurate and personalized but also minimally invasive, leading to better patient outcomes.
What We Offer
Technology
- Advanced Imaging Modalities
At IGTT, we utilize a wide range of imaging technologies—from conventional MRI, CT, PET, SPECT, Ultrasound to more specialized systems such as cone-beam CT (CBCT) integrated into linear accelerators, and state-of-the-art surface scanning solutions. These modalities enable real-time guidance and positioning accuracy, ensuring that therapies precisely target the diseased area while sparing healthy tissues. By combining complementary imaging methods, we gain deeper insights into tumor biology and patient-specific anatomy, empowering clinicians to make well-informed decisions and adapt treatments on-the-fly.
Keywords: MRI, CT, PET, SPECT, CBCT, Surface scanner, Ultrasound
- Theranostic Platforms
Radionuclide theragnostics enables personalised dosimetry-based treatment planning based on the image data acquired (‘molecular radiotherapy’). This entails multimodality imaging for pre-therapy treatment planning and for staging and monitoring response and bio-kinetic modelling to extract the maximum information from data and to inform further treatments. Within the IGTT we strive to foster collaborative research between the local experts to support and advance radionuclide theranostic applications and research. Further, the IGTT as a platform facilitates the exploration of new imaging methods and probes (radio-tracers) to guide and monitor disease evaluation and respective treatments.
- Software & Workflow Optimization
Integration of imaging data into treatment planning systems, real-time monitoring tools, and machine learning–driven analytics.
Expertise
- Clinical & Translational Research
We bridge the gap between bench and bedside, rapidly implementing breakthroughs into clinical practice.
- Biological & Molecular Targeting
Collaboration with biomarker and probe development teams to enable personalized therapies.
- Interventional & Radiation Oncology
From adaptive radiotherapy to minimal invasive interventional procedures.
- Cross-Disciplinary Collaboration
Close ties to physics, radiology, nuclear medicine, biomedical engineering, and industry partners.
Get Involved / Events
- Thesis Seminars
- Wednesday 2.30 pm at Dept. Radiation Oncology
- Tuesday 12:30 pm at Dept. Radiology and Nuclear Medicine
- Workshop in October
Meeting focusing on a selected use-case (around prostate imaging and therapy) with hands-on sessions (teaser date: Fall 2025)
- Social Events
Join us at a summer BBQ on the Donauinsel on May 12th
Contact & Further Information
If you're interested in collaborating, feel free to reach out to us via email. We'll assist in connecting you with the right collaboration partner or share your inquiry through the IGTT mailing list.
- Node Speakers: Gerd Heilemann und Ivo Rausch